The French innovation agency’s approach to risk-sharing is enabling start-ups to attract private capital and make strides in commercialising new technologies.
Three leading institutions have joined forces in a bid for funding to become one of five new University Hospital Institutes being set up through France’s stimulus scheme.
France’s small biopharmaceutical and life science companies have been weakened by the financial crisis and had to face a drastic drop in investment in 2009.